ClinicalTrials.Veeva

Menu

Covid-19 Messaging to Underserved Communities - 2nd Experiment

N

National Bureau of Economic Research, Inc.

Status

Completed

Conditions

Covid19

Treatments

Behavioral: Placebo videos
Behavioral: AMA Acknowledgement Drug Pricing
Behavioral: African American Sender Acknowledgement
Behavioral: White Sender in Informational Videos
Behavioral: African American Sender in Informational Videos.
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: No Racial Inequality Highlighting
Behavioral: Racial Inequality Highlighted
Behavioral: White Sender in Acknowledgement

Study type

Interventional

Funder types

Other

Identifiers

NCT04502056
2029880

Details and patient eligibility

About

The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19. The sample will include African American and white adult Americans and oversample those with less than a college degree.

Full description

Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. Moreover, since our last experiment, the killing of George Floyd by Minnesota police has raised awareness of structural racism in the United States.

The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19.The sample will include African American and white adult Americans and oversample those with less than a college degree.

Enrollment

20,460 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • adults who self-identify as African American or white.
  • an oversample of individuals with less than a college education

Exclusion Criteria:

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20,460 participants in 12 patient groups, including a placebo group

AMA RI - B- B - R
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: Racial Inequality Highlighted
Behavioral: African American Sender in Informational Videos.
Behavioral: African American Sender Acknowledgement
AMA RI - B - B - N
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will not include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: No Racial Inequality Highlighting
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: African American Sender in Informational Videos.
Behavioral: African American Sender Acknowledgement
AMA RI - W - W - R
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: White Sender in Informational Videos
Behavioral: Racial Inequality Highlighted
Behavioral: White Sender in Acknowledgement
AMA RI - W - W - N
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will not include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: No Racial Inequality Highlighting
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: White Sender in Informational Videos
Behavioral: White Sender in Acknowledgement
AMA DP - B- B - R
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will include information on the disproportionate impact on communities of color .
Treatment:
Behavioral: Racial Inequality Highlighted
Behavioral: African American Sender in Informational Videos.
Behavioral: AMA Acknowledgement Drug Pricing
Behavioral: African American Sender Acknowledgement
AMA DP - B- B - N
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - the message on Covid-19 will not include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: No Racial Inequality Highlighting
Behavioral: African American Sender in Informational Videos.
Behavioral: AMA Acknowledgement Drug Pricing
Behavioral: African American Sender Acknowledgement
AMA DP - W- W - R
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: White Sender in Informational Videos
Behavioral: Racial Inequality Highlighted
Behavioral: White Sender in Acknowledgement
Behavioral: AMA Acknowledgement Drug Pricing
AMA DP - W- W - N
Experimental group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will be white - the message on Covid-19 will not include information on the disproportionate impact on communities of color.
Treatment:
Behavioral: No Racial Inequality Highlighting
Behavioral: White Sender in Informational Videos
Behavioral: White Sender in Acknowledgement
Behavioral: AMA Acknowledgement Drug Pricing
Control: AMA RI - B - B
Placebo Comparator group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - No message on Covid-19 will be shown. Acknowledgement Racial Injustice AMA: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. African American Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA
Treatment:
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: African American Sender in Informational Videos.
Behavioral: Placebo videos
Behavioral: African American Sender Acknowledgement
Control: AMA RI - W - W
Placebo Comparator group
Description:
Respondents will be randomized to an AMA statement acknowledging racial injustice read by a white individual. The messenger / doctor in the follow-up AMA videos will also be white - No message on Covid-19 will be shown. Acknowledgement Racial Injustice AMA: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice. White Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a white sender in acknowledgment of AMA
Treatment:
Behavioral: Acknowledgement Racial Injustice AMA
Behavioral: White Sender in Informational Videos
Behavioral: White Sender in Acknowledgement
Behavioral: Placebo videos
Control: AMA DP - B - B
Placebo Comparator group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by an African American individual. The messenger / doctor in the follow-up AMA videos will also be African American - No message on Covid-19 will be shown. African American Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA AMA Acknowledgement Drug Pricing: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing
Treatment:
Behavioral: African American Sender in Informational Videos.
Behavioral: AMA Acknowledgement Drug Pricing
Behavioral: Placebo videos
Behavioral: African American Sender Acknowledgement
Control: AMA DP - W - W
Placebo Comparator group
Description:
Respondents will be randomized to an AMA statement acknowledging drug pricing read by a white individual. The messenger / doctor in the follow-up AMA videos will also be white - No message on Covid-19 will be shown. White Sender Acknowledgement: Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a white sender in acknowledgment of AMA AMA Acknowledgement Drug Pricing: Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing
Treatment:
Behavioral: White Sender in Informational Videos
Behavioral: White Sender in Acknowledgement
Behavioral: AMA Acknowledgement Drug Pricing
Behavioral: Placebo videos

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems